Guest guest Posted June 23, 2006 Report Share Posted June 23, 2006 " " Background: Imatinib can induce severe hepatotoxicity, in 1-5% of CML patients " " " " prednisone or methylprednisolone at 25- 40 mg/day resolved hepatotoxicity in 3-8 weeks and allowed imatinib to be resumed at full doses " " " " Corticosteroid were tapered off in 3-5 months without hepatotoxicity recurrence. " " Haematologica. 2006 Jun;91(6 Suppl):ECR27. Corticosteroids can reverse severe imatinib-induced hepatotoxicity. Ferrero D, Pogliani EM, Rege-Cambrin G, Fava C, Mattioli G, Dellacasa C, Campa E, Perfetti P, Fumagalli M, Boccadoro M. Divisione di Ematologia dell' Universita di Torino; Ospedale Molinette ia Genova 3; 10126 Torino Background: Imatinib can induce severe hepatotoxicity, in 1-5% of CML patients, many of whom need permanent imatinib discontinuation. Design and Results: We report 5 CML patients who developed grade 3-4 hepatotoxicity after 2-8 months in imatinib. Different aetiologies of liver damage were ruled out and toxicity recurred in 2 patients with further attempts at low dose imatinib. In all patients prednisone or methylprednisolone at 25- 40 mg/day resolved hepatotoxicity in 3-8 weeks and allowed imatinib to be resumed at full doses. Corticosteroid were tapered off in 3-5 months without hepatotoxicity recurrence. Conclusions: Corticosteroid may avoid discontinuation for hepatotoxicity of the most effective anti-CML therapy. ___ Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.